Link to this page
Biological and Environmental Research Ontology
| Id | http://purl.obolibrary.org/obo/NCIT_C225
http://purl.obolibrary.org/obo/NCIT_C225
|
|---|---|
| Preferred Name | Recombinant Interferon Alfa |
| Definitions |
A class of naturally-isolated or recombinant therapeutic peptides used as antiviral and anti-tumor agents. Alpha interferons are cytokines produced by nucleated cells (predominantly natural killer (NK) leukocytes) upon exposure to live or inactivated virus, double-stranded RNA or bacterial products. These agents bind to specific cell-surface receptors, resulting in the transcription and translation of genes containing an interferon-specific response element. The proteins so produced mediate many complex effects, including antiviral effects (viral protein synthesis); antiproliferative effects (cellular growth inhibition and alteration of cellular differentiation); anticancer effects (interference with oncogene expression); and immune-modulating effects (natural killer cell activation, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity). (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A class of naturally-isolated or recombinant therapeutic peptides used as antiviral and anti-tumor agents. Alpha interferons are cytokines produced by nucleated cells (predominantly natural killer (NK) leukocytes) upon exposure to live or inactivated virus, double-stranded RNA or bacterial products. These agents bind to specific cell-surface receptors, resulting in the transcription and translation of genes containing an interferon-specific response element. The proteins so produced mediate many complex effects, including antiviral effects (viral protein synthesis); antiproliferative effects (cellular growth inhibition and alteration of cellular differentiation); anticancer effects (interference with oncogene expression); and immune-modulating effects (natural killer cell activation, alteration of cell surface antigen expression, and augmentation of lymphocyte and macrophage cytotoxicity). (NCI04) |
|---|---|
| prefLabel | Recombinant Interferon Alfa
|
| label | Recombinant Interferon Alfa
|
| PDQ_Closed_Trial_Search_ID | 40467
|
| code | C225
|
| prefixIRI | NCIT:C225
|
| in_subset |
See more
See less
|
| Display_Name | Recombinant Interferon Alfa
|
| Preferred_Name | Recombinant Interferon Alfa
|
| Contributing_Source | CTRP
|
| Maps_To | Recombinant Interferon Alfa
|
| NCI_Drug_Dictionary_ID | 40467
|
| Legacy Concept Name | Therapeutic_Interferon_Alfa
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 40467
|
| Accepted_Therapeutic_Use_For | See specific agents.
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0002199
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |